Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?

doi:10.5500/wjt.v7.i5.250

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11014)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

785

WORD

337

HTML

6941

Figures (1-3)

341

Tables (1-5)

317

Sum=8721

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1162

Download

1131

Sum=2293

Oct 24, 2017 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Oct 24, 2017; 7(5): 250-259
Published online Oct 24, 2017. doi: 10.5500/wjt.v7.i5.250

Table 5 Advantages and disadvantages of mobilization strategies

Mobilization strategy	Advantages	Disadvantages
Growth factor	Cost effective	No anti-myeloma effect
	Successful mobilization in most patients	Multiple injections and collections
	Predictable schedule	Potential sub-optimal yield
CM	Anti-myeloma effect	Cytopenias
	Increased cell yield	Infection risk
	Fewer apheresis sessions	Hospital admission
		Potential transfusion requirement
		Unpredictable count recovery
Plerixafor	Rapid kinetics	Higher drug cost
	Increased cell yield
	Fewer apheresis sessions

CM: Chemomobilization.

Citation: Wallis WD, Qazilbash MH. Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy? World J Transplant 2017; 7(5): 250-259
URL: https://www.wjgnet.com/2220-3230/full/v7/i5/250.htm
DOI: https://dx.doi.org/10.5500/wjt.v7.i5.250